Processa Pharmaceuticals (PCSA) Insider Trading & Ownership $0.81 -0.06 (-6.59%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals (NASDAQ:PCSA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.00%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$105,895.00Number OfInsiders Selling(Last 12 Months)0 Get PCSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Processa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PCSA Insider Buying and Selling by Quarter Processa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/7/2024David YoungInsiderBuy21,000$2.45$51,450.00 1/31/2024Patrick LinInsiderBuy2,500$2.37$5,925.00 1/30/2024George K NgCEOBuy10,000$2.70$27,000.00 1/30/2024Justin W YorkeDirectorBuy8,000$2.69$21,520.00 (Data available from 1/1/2013 forward) PCSA Insider Trading Activity - Frequently Asked Questions Who is on Processa Pharmaceuticals's Insider Roster? The list of insiders at Processa Pharmaceuticals includes David Young, George K Ng, Justin W Yorke, and Patrick Lin. Learn more on insiders at PCSA. What percentage of Processa Pharmaceuticals stock is owned by insiders? 13.00% of Processa Pharmaceuticals stock is owned by insiders. Learn more on PCSA's insider holdings. Which Processa Pharmaceuticals insiders have been buying company stock? The following insiders have purchased PCSA shares in the last 24 months: David Young ($103,450.00), George K Ng ($27,000.00), Justin W Yorke ($21,520.00), and Patrick Lin ($5,925.00). How much insider buying is happening at Processa Pharmaceuticals? Insiders have purchased a total of 45,500 PCSA shares in the last 24 months for a total of $157,895.00 bought. Processa Pharmaceuticals Key ExecutivesMr. George K. Ng Esq. (Age 50)J.D., CEO & Director Compensation: $402.03kDr. David Young Ph.D. (Age 71)Pharm.D., Co-Founder, President of Research and Development & Director Compensation: $160.2kDr. Sian E. Bigora Ph.D. (Age 64)Pharm.D., Co-Founder and Chief Development & Regulatory Officer Compensation: $184.87kMr. James H. Stanker (Age 66)Chief Financial Officer Compensation: $160.2kMr. Patrick Lin (Age 59)Co-Founder, Chief Business & Strategy Officer Compensation: $117.15kMs. Wendy J. Guy (Age 60)Co-Founder, Chief Administrative Officer & Corporate Secretary Compensation: $94.19kDr. Steven Cha M.D.Senior Vice President of Clinical Research More Insider Trading Tools from MarketBeat Related Companies Conduit Pharmaceuticals Insider Selling Aspira Women's Health Insider Selling Talphera Insider Selling BioCardia Insider Selling Aytu BioPharma Insider Selling Kiora Pharmaceuticals Insider Selling Phio Pharmaceuticals Insider Selling Indaptus Therapeutics Insider Selling Ensysce Biosciences Insider Selling Cyclerion Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:PCSA) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCSA Stock Alerts